Bimeda Biologicals® is pleased to announce the newest addition to their Stimulator® line of modified live virus (MLV) vaccines: Stimulator® 5 + PMH. With this launch, Bimeda Biologicals adds to their ...
Bimeda® Inc. is thrilled to announce their new partnership with The Spirit of Hagyard podcast. Created in 2022, the podcast was developed by Hagyard Equine Medical Institute, a renowned equine veterin...
Bimeda is pleased to announce the launch of the company's first Annual Sustainability Report. The report is now available to read and download on onebimeda.com In early 2022, Bimeda announced the laun...
Global veterinary pharmaceutical and animal health specialist Bimeda has announced its latest significant investment, via the acquisition of South Africa's leading animal health distributor, Afrivet S...
Bimeda is pleased to announce the launch of a new sustainability-focused website, onebimeda.com. The website details Bimeda's sustainability mission statement and the five Sustainability Pillars which...
Bimeda is pleased to announce the appointment of Samuel Cossio as Territory Sales Manager for the states of Idaho, Oregon, and Washington. Sam will be part of the livestock sales team and assist in th...
Bimeda® Inc. announced today the release of KetoMed™ (ketoprofen) (ANADA 200 – 625) for the alleviation of inflammation and pain associated with musculoskeletal disorders in horses. This launch marks ...
Oakbrook Terrace, Illinois- March 7, 2022- Bimeda® Animal Health has announced the expansion of its US product portfolio with the re-introduction of OvaCyst® (gonadorelin) and ProstaMate® (dinoprost t...
Bimeda® Inc. announced the launch of Detomidine Hydrochloride, a sedative and analgesic used to facilitate minor surgical and diagnostic procedures in mature horses and yearlings, to veterinarians. Th...
It is my pleasure to announce the promotion of David Ellefson, D.V.M. to the newly created position of Senior Director, Technical Services North America. Dr. Dave has been employed with Bimeda for the...